Praxis: Shaking The Dust Off Calcium Channel Blockers For Essential Tremor (NASDAQ:PRAX)

Wirestock/iStock via Getty Images


Praxis Precision Medicines (NASDAQ:PRAX) is dedicated to creating remedies for central nervous system ailments. The biopharmaceutical company is currently working on PRAX-944 (also known as ulixacaltamide), which is a potent and selective small molecule T-type Ca2+ channel

Data by YCharts

Treatment Options Care Setting Criteria for Treatment Initial Pharmacotherapy Second-line Therapies Refractory Tremor
Managed by Primary Care Clinicians Most cases Functional or Psychological Disability Caused by Tremor Propranolol or Primidone Gabapentin, Topiramate, and/or Benzodiazepines Adaptive Devices, Deep Brain Stimulation, Thalamotomy, or Botulinum Toxin Injections
Referral to Neurologist Diagnostic Uncertainty, Poor Response to Standard Pharmacotherapies, or Disabling Tremor

CX-8998 improves TETRAS-ADL in ET

Leave a Reply

Your email address will not be published. Required fields are marked *